Annual report pursuant to Section 13 and 15(d)

(LOSS) EARNINGS PER SHARE

v3.23.1
(LOSS) EARNINGS PER SHARE
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
(LOSS) EARNINGS PER SHARE
 18. (LOSS) EARNINGS PER SHARE
The reconciliations of the net income (loss) and the weighted average number of shares used in the computations of basic and diluted loss (earnings) per share attributable to Jushi shareholders are as follows:
Year Ended December 31,
2022 2021 2020
Numerator:
Net (loss) income and comprehensive (loss) income attributable to Jushi shareholders $ (202,324) $ 20,251  $ (210,607)
Dilutive effect of net income from derivative warrants (91,887) (104,594) — 
Net loss and comprehensive loss attributable to Jushi shareholders - diluted $ (294,211) $ (84,343) $ (210,607)
Denominator:
Weighted-average shares of common stock - basic 190,021,550  170,292,035  108,485,158 
Dilutive effect of derivative warrants 14,213,882  31,318,216  — 
Weighted-average shares of common stock - diluted 204,235,432  201,610,251  108,485,158 
(Loss) earnings per share - basic $ (1.06) $ 0.12  $ (1.94)
(Loss) earnings per share - diluted $ (1.44) $ (0.42) $ (1.94)
In August 2021, all the 149,000 previously issued and outstanding Super Voting Shares and all the 4,000,000 previously outstanding Multiple Voting Shares were converted into SVS in accordance with their terms as described in Jushi Holdings Inc.’s Articles of Incorporation. Refer to Note 15 - Equity. The number of basic and diluted weighted-average shares outstanding for 2021 assumes the conversion of the Multi Voting Share and Super Voting Shares into SVS as of the beginning of the year. Other than voting rights, the Multi Voting Shares and Super Voting Shares had the same rights as the SVS and therefore all these shares are treated as the same class of common stock for purposes of the earnings (loss) per share calculations.
The following table summarizes equity instruments that may, in the future, have a dilutive effect on loss per share, but were excluded from consideration in the computation of diluted net loss per share for the years ended December 31, 2022, 2021 and 2020 because the impact of including them would have been anti-dilutive:
December 31,
2022 2021 2020
Stock options 30,752,259  20,429,120  9,573,834 
Non-derivative warrants 30,673,635  29,156,048  36,764,244 
Unvested restricted stock awards 1,156,319  2,859,151  6,438,186 
Convertible promissory notes —  910,000  930,000 
62,582,213  53,354,319  53,706,264